J 2016

HIC1 Expression Distinguishes Intestinal Carcinomas Sensitive to Chemotherapy

JANECKOVA, Lucie, Michal KOLAR, Jiri SVEC, Lucie LANIKOVA, Vendula POSPÍCHALOVÁ et. al.

Basic information

Original name

HIC1 Expression Distinguishes Intestinal Carcinomas Sensitive to Chemotherapy

Authors

JANECKOVA, Lucie, Michal KOLAR, Jiri SVEC, Lucie LANIKOVA, Vendula POSPÍCHALOVÁ (203 Czech Republic, belonging to the institution), Nikol BALOGHOVA, Martina VOJTECHOVA, Eva SLONCOVA, Hynek STRNAD and Vladimir KORINEK (guarantor)

Edition

TRANSLATIONAL ONCOLOGY, New York, ELSEVIER SCIENCE INC, 2016, 1936-5233

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 3.025

RIV identification code

RIV/00216224:14310/16:00111797

Organization unit

Faculty of Science

UT WoS

000374979800002

Keywords in English

Apoptosis; Bnip3L; caspase-12; hair follicles; PCR arrays

Tags

Tags

International impact, Reviewed
Změněno: 11/5/2020 10:28, Mgr. Marie Šípková, DiS.

Abstract

V originále

Neoplastic growth is frequently associated with genomic DNA methylation that causes transcriptional silencing of tumor suppressor genes. We used a collection of colorectal polyps and carcinomas in combination with bioinformatics analysis of large datasets to study the expression and methylation of Hypermethylated in cancer 1 (HIC1), a tumor suppressor gene inactivated in many neoplasms. In premalignant stages, HIC1 expression was decreased, and the decrease was linked to methylation of a specific region in the HIC1 locus. However, in carcinomas, the HIC1 expression was variable and, in some specimens, comparable to healthy tissue. Importantly, high HIC1 production distinguished a specific type of chemotherapy-responsive tumors.